Most local bankers received 10 per cent to 15 per cent bonus increases compared to last year, with raises of as much as 50 ...
Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug ...
Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.
Looking ahead, Morgan Stanley expects PB Fintech's stock to de-rate as core new business performance moderates in FY26.
While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...
Aditya Birla Capital shares rose 3.5% after Morgan Stanley upgraded the stock to 'overweight' with a target price of Rs 247, ...
Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate ...
Morgan Stanley upgraded AB Capital to "overweight" from "equal-weight" and set a target price of Rs 247 per share ...
Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...